Gregory Tarleton, MD
Emergency Medicine · Winston-Salem, NCNPI 1346226016
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 3 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Pfizer accounts for 64.4% of it on its own, with 1 other manufacturer making up the rest.
Across 3 payments — averaging $41.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$81
- CSL Behring$45
Across 117 payments — averaging $4728.56 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Acella Pharmaceuticals, LLC$239K
- Amgen$152K
- GSK$120K
- Ironwood Pharmaceuticals, Inc$24K
- Avion Pharmaceuticals$11K
- Romark Laboratories, LC$8K
What the payments were for
- Food & beverage$125100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 1 | $81 |
| CSL Behring | 2 | $45 |
How this compares
$125 in reported general payments places this provider in the 75th percentile of 1,657 emergency medicine providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 30 | $320 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 39 | $282 |
| Methylprednisolone | 37 | $269 |
| Ondansetron OdtOndansetron | 26 | $217 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 22 | $118 |
| Cyclobenzaprine Hcl | 20 | $97 |
| Tramadol Hcl | 11 | $63 |
Paid to pharmacies, not to this prescriber.
Other emergency medicine in Winston-Salem
- Richard MontgomeryWinston-Salem$3K
- Boyd WashingtonCharlotte$369K
- Aaron CottenRocky Mount$171K
- Frank AgatucciDurham$153K
- Vivek TayalCharlotte$79K
- Charles GerardoDurham$55K
- Steven FolstadMooresville$53K
- Simon MahlerWinston Salem$52K
- Bijal ShahCharlotte$45K
- Dexter MorrisChapel Hill$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.